Comparison of Metoprolol and Tramadol With Remifentanil in Endoscopic Sinus Surgery
Nasal Polyps
About this trial
This is an interventional other trial for Nasal Polyps focused on measuring Drug: remifentanil, Drug: tramadol, Drug: metoprolol, Functional endoscopic sinus surgery, Controlled hypotension
Eligibility Criteria
Inclusion Criteria:
- diagnosis of rhinosinusitis
- indication for functional endoscopic sinus surgery
Exclusion Criteria:
- American Society of Anesthesiologists risk score > 2
- undertreated hypertension
- Haemoglobin A1c test level > 7.5
- pregnancy
- concurrent surgery
- history of drug abuse
- history of or new diagnosis of allergy to any of the study drugs
- history of post-operative nausea and vomiting
Sites / Locations
- Recep Tayyip Erdogan University
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
remifentanil
tramadol + metoprolol
Following an intravenous bolus dose of 0.5 µg/kg remifentanil administered just before the induction of anaesthesia, patients will receive an intravenous infusion of remifentanil at a dose of 0.25-0.5 µg/kg/min throughout the surgery. The rate of infusion will be adjusted to maintain a mean blood pressure within %70-80 of the baseline value. At the end of the surgery, the rate of infusion will be decreased to 0.05 µg/kg/min, and continued until the patient is extubated.
Just before the induction of anaesthesia, an intravenous infusion of 1 mg/kg of tramadol in 100 ml isotonic fluid will be started. The infusion will be completed in 30 minutes using a perfusor. Additionally, following the administration of the neuromuscular blocking agent, 0.1 mg/kg of intravenous metoprolol will be administered within 5 minutes.